This HTML5 document contains 39 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://dx.doi.org/10.1111/
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q84699712
rdf:type
wikibase:Item
schema:description
article scientifique publié en 2009 im Oktober 2009 veröffentlichter wissenschaftlicher Artikel wetenschappelijk artikel наукова стаття, опублікована в жовтні 2009 scientific article published on 01 October 2009 artículu científicu espublizáu n'ochobre de 2009
p:P577
wds:Q84699712-826A05C4-7388-4626-AE7E-C08888E1DF47
wdt:P577
2009-10-01T00:00:00Z
p:P2093
wds:Q84699712-E9CCE9F8-ADA1-4E23-8E3D-DE9F2341A960 wds:Q84699712-468550BE-FBF5-4449-8B2B-14BE9FE1B929
wdt:P2093
Amanda N Fader Peter G Rose
rdfs:label
Abraxane for the treatment of gynecologic cancer patients with severe hypersensitivity reactions to paclitaxel Abraxane for the treatment of gynecologic cancer patients with severe hypersensitivity reactions to paclitaxel
skos:prefLabel
Abraxane for the treatment of gynecologic cancer patients with severe hypersensitivity reactions to paclitaxel Abraxane for the treatment of gynecologic cancer patients with severe hypersensitivity reactions to paclitaxel
schema:name
Abraxane for the treatment of gynecologic cancer patients with severe hypersensitivity reactions to paclitaxel Abraxane for the treatment of gynecologic cancer patients with severe hypersensitivity reactions to paclitaxel
p:P1476
wds:Q84699712-E98E8E1C-8F2C-4BED-A1AC-E6D1B6EFF2D3
wdt:P1476
Abraxane for the treatment of gynecologic cancer patients with severe hypersensitivity reactions to paclitaxel
p:P304
wds:Q84699712-7B458AEC-9B3D-44B6-9252-BEA6988A8941
wdt:P304
1281-1283
p:P31
wds:Q84699712-82CF8E3D-FCD3-4217-B58A-765DCD4A1814
wdt:P31
wd:Q13442814
p:P921
wds:Q84699712-F749FA03-2B77-4BBE-8812-75519B1C3B11
wdt:P921
wd:Q423762
p:P698
wds:Q84699712-441EE176-5026-4D17-88E2-5B2A3C5C5CDF
wdtn:P698
n11:19820391
wdt:P698
19820391
p:P1433
wds:Q84699712-256AB2F6-C3C3-46A5-A6AE-5FB8C4DD72E3
wdt:P1433
wd:Q15749181
p:P433
wds:Q84699712-2E8BC040-0855-4E0B-A532-914973350743
p:P478
wds:Q84699712-D26A4AD4-4191-4EEA-B9ED-4B60185B275C
wdt:P433
7
wdt:P478
19
p:P356
wds:Q84699712-EAD224EC-359B-4510-AAFE-8DCFF551075D
wdtn:P356
n10:IGC.0B013E3181A38E2F
wdt:P356
10.1111/IGC.0B013E3181A38E2F